Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7309 p103
24 July 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Pharmacist was victim of deliberate deception by Shipman

A pharmacist who dispensed prescriptions for diamorphine written by Harold Shipman was the “victim of a deliberate deception by an accomplished liar”, according to the fourth report of the Shipman Inquiry, published last week. Ghislaine Brant worked in the pharmacy next door to Shipman's surgery in Hyde.

However, the report also criticises Mrs Brant. Making a press statement in Manchester Town Hall last week, Dame Janet Smith, chairman of the inquiry, alleged that Mrs Brant had not fulfilled her professional obligations to scrutinise the prescriptions to ensure they were appropriate for the patient or to watch out for signs that a doctor might be prescribing unlawfully or irresponsibly.

In particular, in 1993, Shipman wrote 14 prescriptions in the names of 13 patients, each for a single 30mg ampoule of diamorphine. Dame Janet described these prescriptions as “extremely unusual: it is far too much to administer to a patient who is suffering from the acute pain of a heart attack and too little to prescribe for a patient who has chronic pain caused by cancer”. Cancer patients normally need to be prescribed several ampoules. In fact, none of these 13 patients had cancer and some were dead.

Shipman may have explained the prescriptions as being for patients suffering the acute pain of a heart attack, but a 5mg dose is usual for such an indication. Mrs Brant had told the inquiry she believed that Shipman would administer the appropriate amount and throw the remainder away.

Mrs Brant should have been aware that this pattern of prescribing was unusual and been concerned that Shipman always collected the drugs, the report says. Moreover, had Mrs Brant brought this to the attention of the proper authorities, some lives might have been saved, Dame Janet said. Criticism of Mrs Brant is mitigated, however, because Shipman deliberately set out to win her trust and to erode such professional objectivity as she had towards him.

Mandie Lavin, director of fitness to practise and legal affairs, Royal Pharmaceutical Society, said: “The Society is currently carefully considering the content of the report with regards to the individual pharmacist Mrs Brant and the other information that has been placed in the public domain. The Society will, in due course, have to consider whether any action should be taken.”

Mrs Brant was unavailable to comment, but her employer, Mayfair Chemists (Hyde) Ltd, maintains that she is a conscientious and experienced pharmacist. It says that the prescriptions written by Shipman were all correctly dispensed and Mrs Brant believed that the medicine was to be used by him for the good of his patients. The careful record keeping of the pharmacists and the evidence given by Mrs Brant at the trial of Shipman, were instrumental in his conviction, Mayfair added.

Back to Top


©The Pharmaceutical Journal